WBC
OGN icon

West Branch Capital’s Organon & Co OGN Stock Holding History

West Branch Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26
Closed -$187 – 416
2025
Q4 		$187 Buy
+26
New +$205 ﹤0.01% 406
2023
Q2 		– Sell
-16
Closed -$377 – 464
2023
Q1 		$377 Sell
16
-147
-90% -$3.95K ﹤0.01% 429
2022
Q4 		$4.55K Sell
163
-200
-55% -$5.11K ﹤0.01% 355
2022
Q3 		$8K Hold
363
– – 0.01% 304
2022
Q2 		$12K Hold
363
– – 0.01% 262
2022
Q1 		$13K Hold
363
– – 0.01% 271
2021
Q4 		$11K Buy
363
+200
+123% +$6.51K ﹤0.01% 316
2021
Q3 		$5K Hold
163
– – ﹤0.01% 362
2021
Q2 		$5K Buy
+163
New +$5.37K ﹤0.01% 379

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

West Branch Capital's OGN Position: Q1 2026 in Review

West Branch Capital sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 26 shares — an estimated $187 sold.

West Branch Capital first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $13K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • West Branch Capital reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • West Branch Capital sold 26 Organon & Co shares in Q1 2026, an estimated $187.
  • West Branch Capital first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • West Branch Capital's Organon & Co position peaked at $13K in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on West Branch Capital's 13F filing for Q1 2026, filed 14 Apr 2026.